NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

循環腫瘤細胞市場調查報告:各檢體,各技術,各產品,各用途-至2025年的預測-COVID-19累積的影響

Circulating Tumor Cell Market Research Report by Specimen, by Technology, by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 998404
出版日期 內容資訊 英文 195 Pages
商品交期: 最快1-2個工作天內
價格
循環腫瘤細胞市場調查報告:各檢體,各技術,各產品,各用途-至2025年的預測-COVID-19累積的影響 Circulating Tumor Cell Market Research Report by Specimen, by Technology, by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 195 Pages
簡介

全球循環腫瘤細胞的市場規模,2020年成為84億7,369萬美元/74億2,989萬歐元。該市場,預計至2025年末達155億8,425萬美元/136億6,456萬歐元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。

本報告提供循環腫瘤細胞市場相關調查,市場概要,以及各檢體,各技術,各產品,各用途,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各獻體預測
  • 各產品預測
  • 各用途預測
  • 各地區預測
  • 其他各競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球循環腫瘤細胞市場,各檢體

  • 血液
  • 骨髓
  • 其他體液

第7章 全球循環腫瘤細胞市場,各技術

  • CTC分析
  • CTC的檢測與強化方法
    • 合併方法
    • 密度為基礎的的分離
    • 免疫捕獲
    • 尺寸為基礎的的分離
  • CTC直接檢測方法

第8章 全球循環腫瘤細胞市場,各產品

  • 血液收集管
  • 設備或系統
  • 套件和試劑

第9章 全球循環腫瘤細胞市場,各用途

  • 臨床/液態生物檢體
    • 風險評估
    • 篩檢和監測
  • 調查
    • 癌症幹細胞與腫瘤形成研究
    • 藥物/治療方法的開發

第10章 南北美洲循環腫瘤細胞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區的循環腫瘤細胞市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章 歐洲,中東、非洲的循環腫瘤細胞市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第14章 企業的實用性簡介

  • Advanced Cell Diagnostics, Inc.
  • ApoCell, Inc.
  • Aviva Biosciences
  • Bio-Techne Corporation
  • BioCep Ltd.
  • BIOCEPT, INC.
  • BioFluidica
  • Biolidics Limited
  • Canopus Bioscience Ltd.
  • Creatv MicroTech, Inc.
  • Epic Sciences
  • Fluxion Biosciences, Inc.
  • Greiner Bio One International GmbH
  • Ikonisys Inc.
  • IVDiagnostics
  • LungLife AI, Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec
  • NanoString Technologies, Inc.
  • Precision for Medicine
  • QIAGEN
  • Rarecells Diagnostics
  • ScreenCell
  • STEMCELL Technologies, Inc.
  • Sysmex Corporation
  • Vitatex, Inc

第15章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-A339DAEF9FAB

The Global Circulating Tumor Cell Market size was estimated at USD 8,473.69 Million in 2020 and expected to reach USD 9,614.20 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.79% to reach USD 18,402.54 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Circulating Tumor Cell to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Specimen, the Circulating Tumor Cell Market was studied across Blood, Bone Marrow, and Other Body Fluids.

Based on Technology, the Circulating Tumor Cell Market was studied across CTC Analysis, CTC Detection & Enrichment Methods, and CTC Direct Detection Methods. The CTC Detection & Enrichment Methods is further studied across Combined Methods, Density-based Separation, Immunocapture, and Size-based Separation.

Based on Product, the Circulating Tumor Cell Market was studied across Blood Collection Tubes, Devices or Systems, and Kits & Reagents.

Based on Application, the Circulating Tumor Cell Market was studied across Clinical/ Liquid Biopsy and Research. The Clinical/ Liquid Biopsy is further studied across Risk Assessment and Screening and Monitoring. The Research is further studied across Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development.

Based on Geography, the Circulating Tumor Cell Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Circulating Tumor Cell Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Circulating Tumor Cell Market, including Advanced Cell Diagnostics, Inc., ApoCell, Inc., Aviva Biosciences, Bio-Techne Corporation, BioCep Ltd., BIOCEPT, INC., BioFluidica, Biolidics Limited, Canopus Bioscience Ltd., Creatv MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., IVDiagnostics, LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, NanoString Technologies, Inc., Precision for Medicine, QIAGEN, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, and Vitatex, Inc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Circulating Tumor Cell Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Circulating Tumor Cell Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Circulating Tumor Cell Market?
  • 4. What is the competitive strategic window for opportunities in the Global Circulating Tumor Cell Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Circulating Tumor Cell Market?
  • 6. What is the market share of the leading vendors in the Global Circulating Tumor Cell Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Circulating Tumor Cell Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Specimen Outlook
  • 3.4. Product Outlook
  • 3.5. Technology Outlook
  • 3.6. Application Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased spending in cancer-related therapies
      • 5.1.1.2. Growing prevalence of cancer across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness about CTC therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in bioengineering and biomedical practices
      • 5.1.3.2. Demand for minimally invasive diagnostics in recent years
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations for the approval of CTC technologies
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Circulating Tumor Cell Market, by Specimen

  • 6.1. Introduction
  • 6.2. Blood
  • 6.3. Bone Marrow
  • 6.4. Other Body Fluids

7. Circulating Tumor Cell Market, by Technology

  • 7.1. Introduction
  • 7.2. CTC Analysis
  • 7.3. CTC Detection & Enrichment Methods
    • 7.3.1. Combined Methods
    • 7.3.2. Density-based Separation
    • 7.3.3. Immunocapture
      • 7.3.3.1. Negative Selection
      • 7.3.3.2. Positive Selection
    • 7.3.4. Size-based Separation
      • 7.3.4.1. Membrane-based
      • 7.3.4.2. Microfluidic-based
  • 7.4. CTC Direct Detection Methods

8. Circulating Tumor Cell Market, by Product

  • 8.1. Introduction
  • 8.2. Blood Collection Tubes
  • 8.3. Devices or Systems
  • 8.4. Kits & Reagents

9. Circulating Tumor Cell Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical/ Liquid Biopsy
    • 9.2.1. Risk Assessment
    • 9.2.2. Screening and Monitoring
  • 9.3. Research
    • 9.3.1. Cancer Stem Cell & Tumorigenesis Research
    • 9.3.2. Drug/Therapy Development

10. Americas Circulating Tumor Cell Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Circulating Tumor Cell Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Circulating Tumor Cell Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Advanced Cell Diagnostics, Inc.
  • 14.2. ApoCell, Inc.
  • 14.3. Aviva Biosciences
  • 14.4. Bio-Techne Corporation
  • 14.5. BioCep Ltd.
  • 14.6. BIOCEPT, INC.
  • 14.7. BioFluidica
  • 14.8. Biolidics Limited
  • 14.9. Canopus Bioscience Ltd.
  • 14.10. Creatv MicroTech, Inc.
  • 14.11. Epic Sciences
  • 14.12. Fluxion Biosciences, Inc.
  • 14.13. Greiner Bio One International GmbH
  • 14.14. Ikonisys Inc.
  • 14.15. IVDiagnostics
  • 14.16. LungLife AI, Inc.
  • 14.17. Menarini Silicon Biosystems
  • 14.18. Miltenyi Biotec
  • 14.19. NanoString Technologies, Inc.
  • 14.20. Precision for Medicine
  • 14.21. QIAGEN
  • 14.22. Rarecells Diagnostics
  • 14.23. ScreenCell
  • 14.24. STEMCELL Technologies, Inc.
  • 14.25. Sysmex Corporation
  • 14.26. Vitatex, Inc

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL CIRCULATING TUMOR CELL MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL CIRCULATING TUMOR CELL MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2026
  • FIGURE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 44. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 46. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2026 (USD MILLION)
  • FIGURE 47. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, 2018-2026 (USD MILLION)
  • FIGURE 49. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, 2018-2026 (USD MILLION)
  • FIGURE 51. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 53. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 55. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, 2018-2026 (USD MILLION)
  • FIGURE 60. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2026 (USD MILLION)
  • FIGURE 62. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, 2018-2026 (USD MILLION)
  • FIGURE 64. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, 2018-2026 (USD MILLION)
  • FIGURE 66. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 67. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 68. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 70. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. CALIFORNIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. FLORIDA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. ILLINOIS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. NEW YORK CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. OHIO CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. PENNSYLVANIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. TEXAS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 83. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 84. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 85. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 87. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 88. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 94. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 95. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 96. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 97. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 98. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 99. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 100. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 101. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 102. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 103. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 104. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 105. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 106. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 107. GLOBAL CIRCULATING TUMOR CELL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 108. GLOBAL CIRCULATING TUMOR CELL MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 109. GLOBAL CIRCULATING TUMOR CELL MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 110. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CIRCULATING TUMOR CELL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CIRCULATING TUMOR CELL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. CALIFORNIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. CALIFORNIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CALIFORNIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. CALIFORNIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. FLORIDA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. FLORIDA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FLORIDA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FLORIDA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ILLINOIS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. ILLINOIS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. ILLINOIS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ILLINOIS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. NEW YORK CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NEW YORK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. NEW YORK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. NEW YORK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. OHIO CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. OHIO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. OHIO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. OHIO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PENNSYLVANIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PENNSYLVANIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PENNSYLVANIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PENNSYLVANIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. TEXAS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. TEXAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. TEXAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. TEXAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 163. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 164. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 165. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 166. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 167. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 168. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 169. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 170. GLOBAL CIRCULATING TUMOR CELL MARKET: SCORES
  • TABLE 171. GLOBAL CIRCULATING TUMOR CELL MARKET: BUSINESS STRATEGY
  • TABLE 172. GLOBAL CIRCULATING TUMOR CELL MARKET: PRODUCT SATISFACTION
  • TABLE 173. GLOBAL CIRCULATING TUMOR CELL MARKET: RANKING
  • TABLE 174. GLOBAL CIRCULATING TUMOR CELL MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 175. GLOBAL CIRCULATING TUMOR CELL MARKET: SHARE, BY COMPANY, 2020
  • TABLE 176. GLOBAL CIRCULATING TUMOR CELL MARKET: MERGER & ACQUISITION
  • TABLE 177. GLOBAL CIRCULATING TUMOR CELL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 178. GLOBAL CIRCULATING TUMOR CELL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 179. GLOBAL CIRCULATING TUMOR CELL MARKET: INVESTMENT & FUNDING
  • TABLE 180. GLOBAL CIRCULATING TUMOR CELL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 181. GLOBAL CIRCULATING TUMOR CELL MARKET: LICENSE & PRICING
  • TABLE 182. GLOBAL CIRCULATING TUMOR CELL MARKET: CONTACT DETAILS